U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Sch... (Otsuka Pharmaceutical Co. Ltd. and Brist...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia

Date:11/6/2007

Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb

Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb are collaborative partners in the development and commercialization of ABILIFY in the United States and major European countries.

ABILIFY was discovered by Otsuka Pharmaceutical Co., Ltd. Founded in 1964, Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: 'Otsuka - people creating new products for better health worldwide.' Otsuka researches, develops, manufactures and markets innovative and original products, with a focus on pharmaceutical products for the treatment of diseases and consumer products for the maintenance of everyday health. Otsuka is committed to being a corporation that creates global value, adhering to the high ethical standards required of a company involved in human health and life, maintaining a dynamic corporate culture, and working in harmony with local communities and the natural environment. The Otsuka Pharmaceutical Group comprises 99 companies and employs approximately 31,000 people in 17 countries and regions worldwide. Otsuka and its consolidated subsidiaries earned US$7.2 billion in annual revenues in fiscal 2006.

Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

For more information and FULL PRESCRIBING INFORMATION, including Boxed WARNING, visit: http://www.abilify.com

Visit Otsuka Pharmaceutical Co., Ltd. at: http://www.otsuka-global.com

Visit Bristol-Myers Squibb at: http://www.bms.com

References

(1) Data on file at Otsuka America Pharmaceutical, Inc.

(2) Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-76
'/>"/>

SOURCE Otsuka Pharmaceutical Co., Ltd.
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine news :

1. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
2. Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees
3. Wells Fargo Offers Online Benefit Administration for Business and Individual Healthcare Consumers
4. Administration Anesthetized to Ailments of Nations Children
5. Supratek Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SP1049C for the treatment of metastatic adenocarcinoma of the upper gastrointestinal tract
6. Siemens Medical Solutions Receives CCHIT Certification for Soarian Clinicals With Siemens Pharmacy and Med Administration Check
7. FDA Approves First Anti-Psychotic for Kids
8. FDA Approves New Roche West Nile Virus Blood Screening Test
9. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
10. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
11. FDA Approves SOMA(R) (carisoprodol) 250 mg

Post Your Comments:

(Date:5/22/2013)... May 22, 2013 Diversity Focus and ... This! The performance promotes awareness that physical disabilities ... Handicap This! performance will be held Friday, June 14th ... auditorium. Tickets for Handicap This! can be purchased ... audiences measure the level to which their mind is ...

(Date:5/22/2013)... Scottsdale, AZ (PRWEB) May 22, 2013 ... spend the next year participating in an intensive startup ... deliver valuable products or services and create local jobs ... . , Each year the Edson initiative offers approximately ... funding, office space, mentorship and training to launch their ...

(Date:5/22/2013)... Michigan study challenges previous research that suggests umpire ... study, a collaboration between researchers at U-M and ... into the controversial argument over whether MLB umpires ... of the same race. It found little statistical ... associate professor of sport management at the U-M ...

(Date:5/22/2013)... Over the next two decades, the cost of treating ... than double, topping more than $180 billion a year, ... the increase: an aging population. The report, from the ... was published May 22 in the journal Stroke ... system," Dr. Bruce Ovbiagele, chairman of the department of ...

(Date:5/22/2013)... hospitals may be reaping enormous income for patients ... infections contracted in their intensive care units. , ... the American Journal of Medical Quality , ... develops an avoidable central line-associated bloodstream infection (CLABSI) ... than a similar infection-free patient. Moreover, hospitals earn ...

[0] Handicap This! Comes to Marion, Iowa [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort [0] U-M study challenges notion that umpires call more strikes for pitchers of same race [0] Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report [0] Hospitals profit when patients develop bloodstream infections

... -- Foster care boosts language development in young children who ... at more than 100 children who had lived in institutions ... foster homes when they were about 22 months old, while ... were compared to about 60 young children who lived in ...

... does not promote healing. This is the conclusion ... the current edition of Deutsches rzteblatt International ... In negative-pressure wound therapy (NPWT), wounds are covered ... pressure is applied using an electronically controlled pump. ...

... Radiation Research Institute (JASRI) have successfully produced a first ... 1.2 Angstroms. This light was created using SACLA, a ... RIKEN in February 2011 in Harima, Japan. SACLA (SPring-8 ... the structure of atoms and molecules at a level ...

... reduction in overall cancer death rates translates to the ... and 2007, according to the latest statistics from the ... and its companion consumer publication Cancer Facts & Figures ... of the population equally. A special section of the ...

... published today in the journal Child Development ... "gut sense" of numbers can lead to a mathematical ... This inaccurate number sense is just one cause of ... Dr. Michele Mazzocco of the Kennedy Krieger Institute. ...

... News) -- The roots of gray hair may lie in ... stem cells, the cells that make and store the pigments ... Using mouse models, researchers at NYU Langone Medical Center found ... may explain how these stem cells work together to produce ...

Cached Medicine News:Health News:Language Delays Seen in Kids in Institutions Beyond Age 2 2 Health News:First X-ray lasing of SACLA 2 Health News:American Cancer Society report finds continued progress in reducing cancer mortality 2 Health News:American Cancer Society report finds continued progress in reducing cancer mortality 3 Health News:American Cancer Society report finds continued progress in reducing cancer mortality 4 Health News:Poor 'gut sense' of numbers contributes to persistent math difficulties 2 Health News:Poor 'gut sense' of numbers contributes to persistent math difficulties 3 Health News:Mouse Study Uncovers the Roots of Gray Hair 2

Language Delays Seen in Kids in Institutions Beyond Age 2 No healing in a vacuum First X-ray lasing of SACLA American Cancer Society report finds continued progress in reducing cancer mortality Poor 'gut sense' of numbers contributes to persistent math difficulties Mouse Study Uncovers the Roots of Gray Hair

(Date:5/22/2013)... Mai 2013 Kepner-Tregoe (KT), das ... heute bekannt, dass der Veteran von 13 ... zum Hauptgeschäftsführer ernannt wurde. Geraghty,s Erfahrung umfasst ... er zahlreiche Führungspositionen bei Fertigungsunternehmen innehielt. Er ... der als Kepner-Tregoe Hauptgeschäftsführer gedient hat, in ...

(Date:5/22/2013)... -- STEPh, Inc., a full service medical communications company, ... site ( http://www.stephreports.com ) dedicated to investigational ... Reports STEPh Reports are comprehensive critical reviews ... Report assesses the competitive landscape by individual drug monograph, ... specific key issues. STEPh Reports are written by individuals ...

(Date:5/22/2013)... 22, 2013 Hemoglobin A1C levels increased ... Type 2 diabetes, while modest improvements in A1C ... and can lead to substantial healthcare cost savings, ... Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th ... sponsored by Valeritas, makers of the V-Go ® ...

Breaking Medicine Technology:Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2 Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3 Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6

[0] Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer [0] Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site [0] Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance

... Cardinal Health today announced that the Federal Trade ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for ... distributor serving the New York metropolitan area. Cardinal Health ... About Cardinal Health Headquartered ...

... Weiss, president and founder of Breastcancer.org and a breast ... the U.S. Food and Drug Administration prior to the ... for Avastin,s use in metastatic HER2-negative breast cancer. In ... removing Avastin,s approval to treat breast cancer, Breastcancer.org is ...

Cached Medicine Technology:Cardinal Health Receives Regulatory Clearance for Kinray Acquisition 2 Cardinal Health Receives Regulatory Clearance for Kinray Acquisition 3 Non-Profit Breastcancer.org Shares Concerns with FDA on Avastin Breast Cancer Recommendation 2 Non-Profit Breastcancer.org Shares Concerns with FDA on Avastin Breast Cancer Recommendation 3

Cardinal Health Receives Regulatory Clearance for Kinray Acquisition Non-Profit Breastcancer.org Shares Concerns with FDA on Avastin Breast Cancer Recommendation

Fastest, easiest and least expensive method for measuring exophthalmos. By sighting at right angles, this device eliminates parallax and allows the clinician to measure the amount of protrusion or bu...

1-Day Acuvue brand contact lenses offer the healthiest, most convenient way to wear contact lenses. There's no lens care or messy solutions required, just wear them one day and throw them away....

PLX40s, 40 Watt Sealed CO2 Laser System....

... to quickly deliver up to 250 millijoules ... powerful single-pulse ablation. This type of high-energy ... and cleanest CO2 surgical laser available today. ... the independent adjustment of pulse energy and ...

Medicine Products:

Luedde Exophthalmometer 1-Day Acuvue 40 Watt Sealed CO2 Laser System UltraPulse SurgiTouch CO2 Laser System